What is polymyalgia rheumatica? Everything you need to know

Written in association with: Dr Kirsten Mackay
Published:
Edited by: Conor Lynch

In this article, highly esteemed consultant rheumatologist, Dr Kirsten Mackay, details what polymyalgia rheumatica is, whilst also outlining the associated symptoms, causes, and treatment options.

 

What is polymyalgia rheumatica?

Polymyalgia rheumatica (PMR) is an inflammatory disorder that primarily affects older adults, typically those over the age of 65, but it can occur occasionally in those aged 50.


It is characterised by muscle pain and stiffness, particularly in both shoulders, upper back and neck, and hips/ buttocks/thighs.

These symptoms can significantly impact daily activities and overall quality of life.

 

Symptoms

The most common symptoms of PMR include bilateral shoulder pain, morning stiffness usually lasting more than 30 minutes, and significant fatigue. Patients may also experience systemic symptoms such as low-grade fever, weight loss, and a general feeling of malaise. The pain usually worsens with rest and improves with movement, which can be confusing for those unfamiliar with the condition.

 

Diagnosis

Diagnosing PMR can be challenging due to its similarity to other conditions like rheumatoid arthritis or fibromyalgia. A thorough medical history and physical examination are essential.

Blood tests measuring inflammation markers, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are commonly used to support the diagnosis. Imaging studies may also be employed to rule out other causes of joint pain.

 

Causes and risk factors

The exact cause of PMR remains unclear, but it is believed to involve an autoimmune response where the body’s immune system mistakenly attacks its own tissues. Genetic factors play a role; individuals of Northern European descent are at higher risk. Additionally, there is a notable association between PMR and giant cell arteritis, another inflammatory condition affecting blood vessels.

 

Treatment options

The primary treatment for PMR involves corticosteroids, which effectively reduce inflammation and alleviate symptoms. Most patients experience significant relief within a few days of starting treatment. Doctors typically begin with a moderate dose and gradually taper off treatment over about 12 months as symptoms improve. Physical therapy and stretching exercises are also beneficial in maintaining mobility and strength.

 

Living with PMR

Managing PMR requires ongoing communication with healthcare providers to monitor symptoms and adjust treatment plans as necessary. Adopting a healthy lifestyle that includes regular exercise, a balanced diet, and stress management techniques can enhance overall well-being.


If you are experiencing the symptoms of polymyalgia rheumatica, and would like to book an appointment with Dr Kirsten Mackay, visit her Top Doctors profile

By Dr Kirsten Mackay
Rheumatology

Dr Kirsten Mackay is a highly distinguished consultant rheumatologist in Devon, with a high level of expertise in osteoporosis, spondyloarthritis and joint injections.  She specialises in all aspects of rheumatology, including various forms of rheumatism, joint pain, back pain, osteoporosis, connective tissue diseases, vasculitis and polymyalgia rheumatica (PMR). She has a particular interest in early inflammatory arthritis, such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, as well as biologic therapies, gout and temporal arteritis (Giant Cell Arteritis)

Dr Mackay earned her medical degree and surgical qualification from Bristol University's Medical School, before going on to undertake her training in general medicine at Southmead and Frenchay Hospitals in Bristol, Northwick Park Hospital in London, and in Queensland, Australia. She then pursued advanced specialisation in rheumatology, training at several prestigious institutions including the Royal National Hospital for Rheumatic Diseases in Bath, the University of Oxford, St. Vincent's Hospital in Dublin, Northwick Park Hospital in London, and Frenchay Hospital in Bristol.

Her research, conducted at the Wellcome Trust Centre for Human Genetics at the University of Oxford, was funded by an Arthritis Research UK fellowship, and her findings have been published in leading medical journals. She was notably awarded a doctorate in medicine by the University of Bath in recognition of her contributions. She has, to date, published extensively within various peer-reviewed publications and medical journals. She has been the National Institute of Health research (NIHR) national clinical co-lead for musculoskeletal research.

She has extensive experience and thoroughly enjoys medical education for doctors in training, allied health professionals and patients, holding a wide variety of roles, many of them national.

View Profile

Overall assessment of their patients


  • Related procedures
  • Platelet-rich plasma
    Ozone therapy
    Neuropathic pain
    Vasculitis
    Elbow Pain
    Bursitis
    Knee osteoarthritis
    Growth factors
    Trapped nerve
    Spinal osteoarthritis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.